Matthew C. Riddle

Oregon Health & Science University — United States

Medicine · Health Sciences

72h-index26.4kcitations316works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Treatment and Management(203), Diabetes Management and Research(198), Metabolism, Diabetes, and Cancer(66), Pancreatic function and diabetes(53), Diabetes, Cardiovascular Risks, and Lipoproteins(42)

Publications315 total

2012-LB: AI-Based Meal Detection Enables Fully-Automated Pramlintide and Insulin Closed-Loop System to Improve Postmeal Glucose in Type 1 Diabetes (T1D)
Diabetes·2025
The Modern Role of Basal Insulin in Advancing Therapy in People With Type 2 Diabetes
Diabetes Care·2025· 6 citedOpen Access
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
The Lancet Diabetes & Endocrinology·2025· 22 cited
Reducing Bias in Academic Publishing: The Diabetes Care Approach.
UNC Libraries·2025Open Access
Back Cover
Diabetes Obesity and Metabolism·2024Open Access
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure
Journal of the American College of Cardiology·2024· 8 citedOpen Access
ADO09, a co‐formulation of pramlintide and insulin A21G, lowers body weight versus insulin lispro in type 1 diabetes
Diabetes Obesity and Metabolism·2024· 4 citedOpen Access
Author response for "ADO09, a co‐formulation of pramlintide and insulin A21G, lowers body weight versus insulin lispro in type 1 diabetes"
2024
Author response for "ADO09, a co‐formulation of pramlintide and insulin A21G, lowers body weight versus insulin lispro in type 1 diabetes"
2024
Erratum. Individualizing Treatment of Type 2 Diabetes After Metformin: More Insights From GRADE. Diabetes Care 2024;47:556–561
Diabetes Care·2024Open Access
Individualizing Treatment of Type 2 Diabetes After Metformin: More Insights From GRADE
Diabetes Care·2024· 1 citedOpen Access
Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events
JACC Heart Failure·2023· 44 citedOpen Access
Use of Real-World Data in Population Science to Improve the Prevention and Care of Diabetes-Related Outcomes
Diabetes Care·2023· 29 citedOpen Access
Cover Image
Diabetes Obesity and Metabolism·2023Open Access
Reducing Bias in Academic Publishing: The<i>Diabetes Care</i>Approach
Diabetes Care·2023· 1 citedOpen Access
A co‐formulation of pramlintide and insulin <scp>A21G</scp> ( <scp>ADO09</scp> ) improves postprandial glucose and short‐term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes
Diabetes Obesity and Metabolism·2023· 10 cited
Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The <scp>ELIXA</scp> trial
Diabetes Obesity and Metabolism·2022Open Access
Author response for "A co‐formulation of pramlintide and insulin A21G (ADO09) improves post‐prandial glucose and short‐term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes"
2022
Author response for "Effect of Lixisenatide on Natriuretic Peptides in People With Type 2 Diabetes And Recent Acute Coronary Syndrome: The ELIXA Trial"
2022
Author response for "Effect of Lixisenatide on Natriuretic Peptides in People With Type 2 Diabetes And Recent Acute Coronary Syndrome: The ELIXA Trial"
2022
page 1 of 16Next →

Frequent Co-authors

Hertzel C. Gerstein(13), Lawrence A. Leiter(11), Rafael Díaz(9), Julio Rosenstock(8), Jeffrey L. Probstfield(7), Philip Home(7), William C. Cushman(6), M. Ziemen(6), Helen M. Colhoun(5), Mark Lakshmanan(5), Charles Atisso(5), Jan Basile(5), Mátyás Keltai(5), Fernando Laņas(5), Patricio López‐Jaramillo(5), Nana Pogosova(5), Peter Raubenheimer(5), Jonathan E. Shaw(5), Wayne Huey‐Herng Sheu(5), Theodora Temelkova‐Kurktschiev(5)